Mode
Text Size
Log in / Sign up
N/A N=73 Randomized Treatment

Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass

Acute Kidney Injury

Enrolled (actual)
73
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Number of Participants With Negative Fluid Balance on Postop Day 1 — 21; 29 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Furosemide (Drug); Peritoneal Dialysis (Procedure)
Age
Pediatric
Sex
All
Sponsor
Children's Hospital Medical Center, Cincinnati
Primary completion
Jun 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Negative Fluid Balance on Postop Day 1
21; 29
SECONDARY
Respiratory Support Administered
4; 3
SECONDARY
NGAL Concentration
SECONDARY
Duration of Cardiac ICU Stay
9; 7
SECONDARY
Duration of Hospital Stay
15; 14
SECONDARY
All Cause Mortality
3; 1
SECONDARY
Renal/Electrolyte Abnormalities
6; 4
SECONDARY
Doses of Potassium Chloride or Arginine Chloride Required
2; 1
SECONDARY
B-Natriuretic Peptide
1334; 1168; 1110; 663
SECONDARY
Modified Oxygenation Index
4; 4; 3.8; 2.8

Summary

Acute kidney injury (AKI) after cardiopulmonary bypass (CPB) in infants is common and associated with poor outcomes. Peritoneal dialysis (PD) and furosemide have been used to attain negative fluid balance due to AKI induced oliguria, but have not been compared prospectively. The investigators will prospectively compare outcomes of infants with oliguria after CPB randomized to PD vs. furosemide with the hypothesis that infants receiving PD have superior outcomes.

Eligibility Criteria

Inclusion Criteria

  • Age less than 6 months of age;
  • Undergoing cardiothoracic surgery with CPB;
  • Planned placement of PD catheter per institutional standard of care criteria.

Exclusion Criteria

  • Pre-existing chronic kidney disease stage 3 or above (correlating with estimated GFR<60 ml/min/m2, which will be calculated using routine preoperative serum creatinine value using the modified Schwartz equation).
  • Known history of allergy to furosemide.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01709227). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search